Data as of Jan 29
| +0.19 / +3.04%|
The 4 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 16.00, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +148.83% increase from the last price of 6.43.
The current consensus among 4 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.